| Authors: |
Driskill MM; Department of Chemical Engineering, Stanford University, Stanford, CA 94305, USA., Coates IA; Department of Chemical Engineering, Stanford University, Stanford, CA 94305, USA., Hurst PJ; Department of Chemistry, Stanford University, Stanford, CA 94305, USA., Rajesh NU; Department of Bioengineering, Stanford University, Stanford, CA 94305, USA., Dulay MT; Department of Radiology, Stanford University, Stanford, CA 94305, USA., Waymouth RM; Department of Chemistry, Stanford University, Stanford, CA 94305, USA., Akahata W; VLP Therapeutics, Inc., Gaithersburg, MD 20878, USA; VLP Therapeutics Japan, Inc., Nishi-Shinbashi, Minato-ku, Tokyo 105-0003, Japan., Matsuda K; VLP Therapeutics, Inc., Gaithersburg, MD 20878, USA., Smith JF; VLP Therapeutics, Inc., Gaithersburg, MD 20878, USA., Jacobson GB; Department of Radiology, Stanford University, Stanford, CA 94305, USA., Perry JL; Center for Nanotechnology in Drug Delivery and Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, NC 27599, USA., Tian S; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. Electronic address: smtian@email.unc.edu., DeSimone JM; Department of Chemical Engineering, Stanford University, Stanford, CA 94305, USA; Department of Radiology, Stanford University, Stanford, CA 94305, USA. Electronic address: jmdesimone@stanford.edu. |
